Last $0.92 USD
Change Today 0.00 / 0.00%
Volume 104.4K
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Key Developments

Implant Sciences Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2014

Implant Sciences Corp. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the quarter, revenues were $2,141,000 against $3,150,00 a year ago. The decrease in revenue is due primarily to: a 31.6% decrease in the number of QS-B220 desktop units sold in the three months ended December 31, 2014, due to decreased shipments to U.S. air cargo screening facilities in the current three month period and a 3.6% decrease in the average unit sales prices, which resulted in a 34.0% decrease in QS-B220 revenues; a 25.0% decrease in the number of QS-H150 handheld units sold, compared to the prior period, due to decreased shipments to Japan and a 15.6% decrease in the average unit sales prices, which resulted in a 36.7% decrease in QS-H150 revenues,  offset partially by a 50.4% increase in sales of parts and supplies. Loss from operation was $4,119,000 against $2,707,000 a year ago. Net loss was $6,244,000 against $4,381,000 a year ago. Net loss per share, basic and diluted was $0.09 against $0.07 a year ago. Adjusted LBITDA was $3,515,000 against $1,891,000 a year ago. The increase in the net loss is primarily due to costs incurred due to the resignation of former CEO, decreased sales and gross margin and an increase in interest expense. For the six months, revenues were $4,010,000 against $4,315,00 a year ago. Loss from operation was $7,460,000 against $7,133,000 a year ago. Net loss was $11,619,000 against $10,402,000 a year ago. Net loss per share, basic and diluted was $0.17 against $0.18 a year ago. Adjusted LBITDA was $5,843,000 against $4,598,000 a year ago.

Implant Sciences Corp. to Report Q2, 2015 Results on Feb 17, 2015

Implant Sciences Corp. announced that they will report Q2, 2015 results on Feb 17, 2015

Implant Sciences Corp., Q2 2015 Earnings Call, Feb 17, 2015

Implant Sciences Corp., Q2 2015 Earnings Call, Feb 17, 2015

Implant Sciences Corp. Appoints Robert Liscouski as Executive Vice President

Implant Sciences Corporation announced the appointment of Robert Liscouski into the newly created position of Executive Vice President. Mr. Liscouski will manage and drive the company's business strategy, business development and branding efforts. Mr. Liscouski will report to Dr. William McGann, Chief Executive Officer. Mr. Liscouski will continue to serve on the company's Board of Directors. Mr. Liscouski is a recognized international security and counterterrorism expert with more than 30 years of experience as a senior government official, business leader, entrepreneur, special agent and law enforcement officer. He has been on the Implant Sciences Board of Directors since 2009 and is a frequent contributor to CNN, Fox News, and other business and security media.

Implant Sciences Corporation Appoints William McGann as its Chief Executive Officer

Implant Sciences Corporation announced that chief operating officer William McGann has been named as the Company's chief executive officer, effective immediately. Dr. McGann replaces Glenn D. Bolduc, who resigned his position on January 16, 2015 as chief executive officer of the company and his seat on the company's board of directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.92 USD 0.00

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $169.14 USD -1.80
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.